Tag Archives: Defective Drug Recall

Featured Stories

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...
FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Hospira Recalls Hydromorphone Injection on Overdose Concern

Hospira, Inc. just announced a recall of its Hydromorphone Injection due to overdose concerns, the U.S. Food & Drug Administration (FDA) just announced. The recall involves one lot of Hydromorphone Injection, USP, 2 mg/mL (C-II), 1 mL fill in 2.5 … Continue reading

Posted in Pharmaceuticals | Tagged |

Class I Recall Issued For Potentially Contaminated Ultrasound Gel

A Class I recall has been issued for potentially contaminated ultrasound gel, the U.S. Food & Drug Administration (FDA) just announced. A Class I recall involves a situation in which there exists a reasonable probability that the use of or … Continue reading

Posted in Defective Medical Devices | Tagged |

Epinephrine Injections Recalled For Discoloration, Particle Contamination

Epinephrine injections, distributed by American Regent, are being recalled for discoloration and particle contamination, the U.S. Food & Drug Administration (FDA) just announced. The nationwide recall is being conducted at the retail/hospital level and involves Epinephrine Injection, USP, 1:1000, 1 … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged |

X-Rock Male Supplement Recalled

X-ROCK INDUSTRIES, an independent distributor of X-Rock products, is recalling some of its X-Rock Male Supplements, the U.S. Food & Drug Administration (FDA) announced. The finished product of X-Rock for Men—sold by XROCK INDUSTRIES and under the brand name X-Rock—was … Continue reading

Posted in Pharmaceuticals | Tagged |

16 Sickened by Contaminated Ultrasound Gel FDA Says

At least 16 people have been sickened by contaminated ultrasound gel, the U.S. Food & Drug Administration (FDA) just announced. The agency notified health care professionals and facilities to stop their use of Other‐Sonic Generic Ultrasound Transmission Gel.

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged |

Hospira Recalls Morphine Injections, Syringes may be Over-Filled

Hospira, Inc. is recalling morphine injections because the syringes may be over-filled, the U.S. Food & Drug Administration just announced. The recall involves one lot of Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject, … Continue reading

Posted in Pharmaceuticals | Tagged |

Warfarin Recall Issued, Tablets may be Mislabled

Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is issuing a Drug Recall for one lot—Lot # 284081—of J< "http://www.yourlawyer.com/practice_areas/defective_drugs">antoven® Warfarin Sodium, USP, 3mg Tablets. This is an anticoagulant with an expiration date of September 2012, NDC # 0832-1214-00. Upsher-Smith Laboratories … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , |

Shaping Beauty Recalls Weight Loss Pills

Shaping Beauty, Inc. of Southampton, Pennsylvania, has been informed by the U.S. Food and Drug Administration (FDA) < "http://www.yourlawyer.com/practice_areas/defective_drugs">that a weight loss dietary supplement it sold and marketed contains an undeclared drug ingredient. FDA lab analyses of the defective drugs … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.